MedPath
HSA Approval

PROGESIC-250 SUSPENSION 250 mg/5 ml

SIN06068P

PROGESIC-250 SUSPENSION 250 mg/5 ml

PROGESIC-250 SUSPENSION 250 mg/5 ml

May 20, 1991

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SUSPENSION

**Dosage and Administration** ![Progesic Suspension Dosage Table 1](https://cdn.medpath.com/drug/dosage/20240520/1fe5aa5b4ab0d99f19f3d4c2cd631d2b.png) **Progesic** Suspension may be taken before or after food with a glass of water. Do not exceed the stated dose. If fever does not subside in 36 hours, a doctor should be consulted.

ORAL

Medical Information

**Actions and Uses** **Progesic** Suspension contains paracetamol – a modern analgesic that relieves pain and fever like aspirin but unlike aspirin may be used with confidence in children. **Progesic** Suspension is recommended for the relief of fever and pain such as toothache, and headache in children.

**Contraindications** Like other paracetamol preparations, **Progesic** Suspension should not be used in patients who have shown hypersensitivity to Paracetamol.

N02BE01

paracetamol

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

PARACETAMOL

250 mg/5 ml

Acetaminophen

Documents

Package Inserts

Progesic-250 suspension PI.pdf

Approved: November 30, 2020

Download

Patient Information Leaflets

Progesic-250 suspension PIL.pdf

Approved: November 30, 2020

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROGESIC-250 SUSPENSION 250 mg/5 ml - HSA Approval | MedPath